dopamine

H54 Investigation of the effects of dopamine antagonist medication on cognition in huntington’s disease
Kate Harris, Sarah L Mason, Roger Barker

Journal of Neurology, Neurosurgery & Psychiatry Sep 2018, 89 (Suppl 1) A86; DOI: 10.1136/jnnp-2018-EHDN.232
I22 Intranasal administration of mesenchymal stem cells ameliorates the abnormal dopamine transmission system and inflammatory reaction in the R6/2 mouse model of huntington disease
Libo Yu-Taeger, Janice Stricker-Shaver, Katrin Arnold, Patrycja Bambynek-Dziuk, Arianna Novati, Elisabeth Singer, Fabian Claire, Janine Magg, Olaf Riess, Alexandra Stolzing, Lusine Danielyan, Hoa Huu Phuc Nguyen

Journal of Neurology, Neurosurgery & Psychiatry Sep 2018, 89 (Suppl 1) A96; DOI: 10.1136/jnnp-2018-EHDN.258
Pathophysiological and cognitive mechanisms of fatigue in multiple sclerosis
Zina-Mary Manjaly, Neil A Harrison, Hugo D Critchley, Cao Tri Do, Gabor Stefanics, Nicole Wenderoth, Andreas Lutterotti, Alfred Müller, Klaas Enno Stephan

Journal of Neurology, Neurosurgery & Psychiatry Jun 2019, 90 (6) 642-651; DOI: 10.1136/jnnp-2018-320050
Subthalamic stimulation and neuropsychiatric symptoms in Parkinson’s disease: results from a long-term follow-up cohort study
Marie Abbes, Eugénie Lhommée, Stéphane Thobois, Hélène Klinger, Emmanuelle Schmitt, Amélie Bichon, Anna Castrioto, Jing Xie, Valérie Fraix, Andrea Kistner, Pierre Pélissier, Éric Seigneuret, Stéphan Chabardès, Patrick Mertens, Emmanuel Broussolle, Elena Moro, Paul Krack

Journal of Neurology, Neurosurgery & Psychiatry Aug 2018, 89 (8) 836-843; DOI: 10.1136/jnnp-2017-316373
M17 Targeting Dopamine D1-histamine H3 Receptor Heteromers As A Therapeutical Strategy To Prevent Cognitive Deficits And Neurodegeneration In Huntington’s Disease
MP Cañadell, D Moreno-Delgado, M Rodríguez-Ruiz, E Moreno, J Botta, P Gasperini, A Cordomí, LA Howell, G Navarro, V Casadó, S Ferré, M Guzmán, L Pardo, J Alberch, EI Canela, C Lluís, P J McCormick, S Ginés

Journal of Neurology, Neurosurgery & Psychiatry Sep 2014, 85 (Suppl 1) A100; DOI: 10.1136/jnnp-2014-309032.289
C4 Motivation and reward seeking in HD mouse lines: possible association with ventral striatal mHTT load and dopamine receptor loss
Kyle Fears, Timothy Stone, Linda Elliston, Zubeyde Bayram-Weston, David Harrison, Stephen B Dunnett, Lesley Jones, Simon Brooks

Journal of Neurology, Neurosurgery & Psychiatry Sep 2016, 87 (Suppl 1) A28; DOI: 10.1136/jnnp-2016-314597.84
B34 Dopamine imbalance in huntington’s disease: when the inhibition of autophagy can lead to cell catastrophe
Marina Melone, Chiara Vidoni, A Castiglioni, C Seca, Ciro Isidoro

Journal of Neurology, Neurosurgery & Psychiatry Sep 2016, 87 (Suppl 1) A21; DOI: 10.1136/jnnp-2016-314597.65
A16 Exercise-induced brain repair in neurodegeneration: what can we learn from parkinson’s disease?
Beth Fisher

Journal of Neurology, Neurosurgery & Psychiatry Sep 2016, 87 (Suppl 1) A5; DOI: 10.1136/jnnp-2016-314597.16
Iowa gambling task impairment in Parkinson's disease can be normalised by reduction of dopaminergic medication after subthalamic stimulation
Anna Castrioto, Aurélie Funkiewiez, Bettina Debû, Roshan Cools, Eugénie Lhommée, Claire Ardouin, Valérie Fraix, Stephan Chabardès, Trevor W Robbins, Pierre Pollak, Paul Krack

Journal of Neurology, Neurosurgery & Psychiatry Feb 2015, 86 (2) 186-190; DOI: 10.1136/jnnp-2013-307146
B38 Excessive Monoamine Oxidase A/b Activity Contributes To Stress-induced Neuronal Death In Huntington Disease
J Ooi, MR Hayden, MA Pouladi

Journal of Neurology, Neurosurgery & Psychiatry Sep 2014, 85 (Suppl 1) A22; DOI: 10.1136/jnnp-2014-309032.66

Main menu

dopamine

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

dopamine

Pages